>Mercado europeu de preenchimentos dérmicos, por tipo de produto (preenchimentos dérmicos biodegradáveis, preenchimentos dérmicos não biodegradáveis), tipo de material (preenchimentos dérmicos naturais, preenchimentos dérmicos sintéticos), aplicação (lifting facial, rinoplastia, cirurgia reconstrutiva , correção da linha facial, realce labial, flacidez Pele, depressão nas bochechas, suavização da pele, medicina dentária, restauração estética, ameixa labial, tratamento de cicatrizes, aumento do queixo, tratamento de lipoatrofia, rejuvenescimento do lóbulo da orelha e outros), tipo de medicamento (de marca, genérico ), utilizador final (clínicas de dermatologia, centros de cirurgia ambulatória, hospitais , Institutos de Investigação Académica e Outros), Canal de Distribuição (Licitação Direta, Drogarias, Farmácia de Retalho, Farmácia Online e Outros) - Tendências e Previsão do Setor para 2029.
Análise e visão do mercado europeu de preenchimentos dérmicos
O preenchimento dérmico consiste em substâncias semelhantes a gel que são injetadas sob a pele para restaurar o volume perdido, geralmente rugas e linhas suaves ou melhorar os contornos faciais. O uso de preenchimentos dérmicos tem crescido rapidamente nos últimos anos devido a várias ofertas de melhorias estéticas e de rejuvenescimento que anteriormente só eram possíveis com cirurgias. Estão a tornar-se muito populares nos métodos de rejuvenescimento facial. Por ser um preenchimento dérmico minimamente invasivo apresenta resultados instantâneos em terapias cosméticas de reposição de volume. Estes aparelhos proporcionam volume ao rosto, potenciam e melhoram a qualidade da pele. Vários métodos, como injeções, são utilizados para o aumento. Estes preenchimentos podem proporcionar lábios mais cheios e carnudos para fins estéticos. Existem muitos tipos de preenchimentos dérmicos que podem ser injetados nos lábios e à volta da boca que mantêm o volume dos lábios de forma temporária ou permanente dependendo do tipo de produto utilizado. Alguns participantes no mercado estão envolvidos em produtos novos e inovadores, e os seus produtos estão em fase de preparação. Durante os últimos anos, novos produtos inovadores de preenchimentos dérmicos foram desenvolvidos para aumentar o crescimento do mercado de preenchimentos dérmicos, e os players do mercado estão a melhorar o seu portefólio de produtos. Muitos players do mercado estão envolvidos no fabrico de preenchimentos dérmicos com inovações que abrem caminho para o crescimento do mercado.
A Data Bridge Market Research analisa que o mercado de preenchimentos dérmicos deverá atingir o valor de 2.119,54 milhões de dólares até 2029, com um CAGR de 10,0% durante o período de previsão 2022-2029.
Métrica de reporte |
Detalhes |
Período de previsão |
2022 a 2029 |
Ano base |
2021 |
Ano histórico |
2020 (personalizável para 2019-2014) |
Unidades Quantitativas |
Receita em milhões de dólares, volumes em unidades, preços em dólares |
Segmentos cobertos |
By Product Type (Biodegradable Dermal Fillers, Non-Biodegradable Dermal Fillers), Material Type (Natural Dermal Fillers, Synthetic Dermal Fillers), Application (Face Lift, Rhinoplasty, Reconstructive Surgery, Facial Line Correction, Lip Enhancement, Sagging Skin, Cheek Depression, Skin Smoothing, Dentistry, Aesthetic Restoration, Lip Plum, Scar Treatment, Chin Augmentation, Lipoatrophy Treatment, Earlobe Rejuvenation and Others), Drug Type (Branded, Generic), End User (Dermatology Clinics, Ambulatory Surgical Centers, Hospitals, Academic Research Institutes And Others), Distribution Channel (Direct Tender, Drug Stores, Retail Pharmacy, Online Pharmacy and Others) |
Countries Covered |
Germany, Italy, France, U.K., Spain, Russia, Netherlands, Switzerland, Belgium, Turkey and Rest Of Europe |
Market Players Covered |
Allergan(A Subsidiary of Abbvie, Inc.), Prollenium Medical Technologies, Suneva Medical, Revance Therapeutics, Inc., FillMed Laboratories, Anika Therapeutics, Inc, Ipsen Pharma, BIOXIS Pharmaceuticals, Zimmer Aesthetic, Zhejiang Jingjia Medical Technology Co. Ltd., Medytox, Contura International ltd., Shanghai Reyoungel Medical Technology Company Limited, Humedix (A subsidiary of HUONS GLOBAL),Galderma Laboratories, L.P., Merz North America, Inc. (A Subsidiary of Merz Pharma),Croma-Pharma GmbH, Sinclair Pharma (A Subsidiary of Huadong Medicine Co., Ltd.),Teoxane, BioPlus Co., Ltd., Amalian, Givaudan, Mesoestetic, Sosum Global, DSM, IBSA Nordic ApS,among others. |
Market Definition
Dermal fillers are substances designed to be injected into the skin to add fullness and volume. The substances used in dermal fillers include Calcium hydroxylapatite (a mineral-like compound found in bones), Hyaluronic acid, Polyalkylimide, Polylactic acid, Polymethyl-methacrylate microspheres (PMMA). Dermal fillers can be classified based on several criteria, including the deep dermis, depth of implantation (a superficial midterms and upper, and subcutaneous levels); longevity of correction (temporary and permanent); allergenicity, the composition of the agent (allografts, semi/fully synthetic, xenografts, or autologous); and stimulatory behavior (physiologic processes of endogenous tissue proliferation) versus replacement fillers (space-replacing effect).
Temporary dermal fillers such as HA and collagen are biodegradable and last from 4 to 9 months. The prospective side effects and dissatisfaction are also short-lived. Therefore, temporary fillers are always used as the first line of therapy to save long-lasting fillers for future patient visits.
Permanent fillers are essentially used in the alteration of deep lines and furrows of the skin, which are beyond normal facial wrinkles. They are considered an excellent option in facial rejuvenation, especially in HIV lipodystrophy. Polymethyl methacrylate (PMMA) is mostly used for safe, effective, and long-lasting effects.
Dermal Fillers Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:
Drivers
- Rising prevalence of minimally-invasive procedures
The use of minimally invasive procedures has been shifted as compared to traditional methods for aesthetic and cosmetics surgeries techniques including laser and other energy-based devices. For the use of surgical or non-surgical procedures, specially-designed instruments have been developed for minimally used procedures. These anti-aging devices help in reducing the visual effects of skin aging by revitalizing and tightening the skin, which gives a younger look.
Minimally-invasive surgery is a procedure conducted with the assistance of a scope of viewing and specially-equipped surgical instruments. It targets facial irregularities including wrinkles and fine lines and decreases volume and contour and unwanted fat. These have essentially no risk of serious adverse events as the procedures allow no cuts or minimal cuts with lesser recovery time which is increasing the demand for use of minimally invasive procedures. Minimally-invasive energy-based treatments for skin tightening, wrinkle reduction, face contouring and skin rejuvenation have a high demand in the world. Other reasons driving the demand for these procedures are increasing aging people and rising requirement of healthcare facilities which can further result in decrease in burden on healthcare facilities.
With rising technological advancements and communications, people are more aware of aesthetic devices and procedures that are well performed in the healthcare field, impacting the adoption of minimally invasive procedures positively in the upcoming era. Thus, the increasing prevalence of minimally invasive procedures is expected to drive growth in the dermal fillers market.
- Increasing geriatric population
The geriatric population is expanding for longer life span and is reported to have increasing skin ageing conditions. The speed of aging population is increasing exponentially in the world whereas European countries have certain cultural, social and economic characteristics in common with similar aspirations. As people start aging, increase in appearance to appear as younger raises which ultimately develops interest in utilization of aesthetic procedures.
Rising improving healthcare delivery and its scenario in the Middle Eastern countries among the percentage of elderly people have resulted in better patients’ outcome services.
Opportunities
- Increasing funding activities for aesthetic research
Plastic surgery, unwanted hair removal, skin tightening, anti-aging, excess fat removal, body contouring and several other cosmetic procedures that are to be performed through minimally invasive procedures follow under medical aesthetic devices that are used for increased appearances, beautification and other improvement part of body. Various foundations and government organizations are investing a large amount in aesthetic research.
- Advancement in the new dermal fillers
Dermal fillers are in the form of gel-like substances, which are injected beneath the skin to restore the lost volume, soften creases and smooth lines. It is also used to enhance facial contours; each year more than 1 million people prefer this popular facial transformation treatment to restore the wrinkles and appearance of facial lines. Dermal fillers are an effective treatment way to look younger without downtime or surgery. Dermal fillers drug is injected into the skin which helps in filling the facial wrinkles. There are different types of dermal fillers drugs available, the most common types are Calcium hydroxylapatite, Hyaluronic acid, Polyalkylimide, Polylactic acid and others. Advancement in the dermal fillers brands will help to boost the demand of the market.
Restrains/ Challenges
- High cost of aesthetic procedures
Cost is always a consideration in the elective procedure. The cost of dermal filler is depending on the type of filler and the amount is used in the treatment. Also, the treatment cost is based on the qualifications and expertise of the person performing the dermal fillers treatment. The cosmetic treatment of dermal filler is a safe outpatient procedure and it is a very popular treatment for restoring lost volume and treating some signs of aging, but the high cost of the procedures is expected to hamper the demand of the market
- Lack of skilled professionals
Aesthetic treatment procedures are of different type’s laser-based technology, energy-based technology and intense pulse light among others. All such techniques need qualified interpersonal skills in order to carry out effective treatment.
Moreover, rapid technological advancement in this field also lead to lack of skilled professionals. Lack of skilled professionals pose major challenge while device handling and carrying out surgical procedures.
Recent Developments
- In April 2022, Sinclair Pharma announced the company has received European CE mark for Perfectha Lidocaine in the treatment of wrinkle correction, facial contouring and volume restoration. This CE certificate results in launch of Perfectha Lidocaine in the UK and all major European markets.
Dermal Fillers Market Segmentation
The dermal fillers market is segmented on the basis of product type, material type, application, drug type, end user and distribution channel. The growth among segments helps you analyses niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
Por tipo de produto
- Enchimentos dérmicos biodegradáveis
- Preenchimentos Dérmicos Não Biodegradáveis
Com base no tipo de produto, o mercado dos preenchimentos dérmicos está segmentado em preenchimentos dérmicos biodegradáveis e preenchimentos dérmicos não biodegradáveis.
Por tipo de material
- Preenchimentos Dérmicos Naturais
- Preenchimentos Dérmicos Sintéticos
Com base no tipo de material, o mercado está segmentado em preenchimentos dérmicos naturais e preenchimentos dérmicos sintéticos.
Por aplicação
- Lifting facial
- Rinoplastia
- Cirurgia Reconstrutiva
- Correção da linha facial
- Aprimoramento labial
- Pele Flacidez
- Depressão nas bochechas
- Suavização da pele
- Odontologia
- Restauração Estética
- Ameixa labial
- Tratamento de cicatrizes
- Aumento do queixo
- Tratamento da Lipoatrofia
- Rejuvenescimento do lóbulo da orelha
- Outros
Com base na aplicação, o mercado está segmentado em lifting facial, rinoplastia, cirurgia reconstrutiva, correção da linha facial, realce labial, flacidez da pele, depressão das bochechas, suavização da pele, medicina dentária, restauração estética, tratamento de cicatrizes, aumento do queixo , tratamento de lipoatrofia, rejuvenescimento do lóbulo da orelha e outros.
Por tipo de medicamento
- Com marca
- Genérico
Com base no tipo de medicamento, o mercado está segmentado em de marca e genérico.
Por utilizador final
- Clínicas Dermatológicas
- Hospitais
- Centros Cirúrgicos Ambulatoriais
- Institutos de Investigação Académica
- Outros
Com base no utilizador final, o mercado está segmentado em clínicas dermatológicas, centros de cirurgia ambulatória, hospitais, institutos de investigação académica e outros.
Por canal de distribuição
- Concurso Direto
- Drogarias
- Farmácia de Retalho
- Farmácia on-line
- Outros
Com base no canal de distribuição, o mercado está segmentado em licitação direta, drogarias, farmácia de retalho, farmácia online e outros.
Análise/perspetivas regionais do mercado de preenchimentos dérmicos
O mercado dos preenchimentos dérmicos é analisado e os insights e tendências do tamanho do mercado são fornecidos por país, por tipo de produto, por tipo de material, por aplicação, por tipo de medicamento, por utilizador final e por canal de distribuição como mencionado acima .
Os países abrangidos no relatório de mercado de preenchimentos dérmicos são a Alemanha, Itália, França, Reino Unido, Espanha, Rússia, Países Baixos, Suíça, Bélgica, Turquia e Resto da Europa.
Espera-se que a Alemanha domine o mercado devido à crescente tecnologia e fiabilidade dos dispositivos de preenchimento dérmico.
A secção do país do relatório também fornece fatores individuais de impacto no mercado e alterações na regulamentação do mercado que impactam as tendências atuais e futuras do mercado. Pontos de dados como a análise da cadeia de valor a jusante e a montante, tendências técnicas e análise das cinco forças de Porter, estudos de caso são alguns dos indicadores utilizados para prever o cenário de mercado para países individuais. Além disso, são considerados a presença e disponibilidade de marcas e os desafios enfrentados devido à grande ou escassa concorrência de marcas locais e nacionais, o impacto das tarifas nacionais e das rotas comerciais, ao mesmo tempo que se fornece uma análise de previsão dos dados do país.
Análise do cenário competitivo e da quota de mercado dos preenchimentos dérmicos
O panorama competitivo do mercado de preenchimentos dérmicos fornece detalhes por concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, presença global, localizações e instalações de produção, capacidades de produção, pontos fortes e fracos da empresa , lançamento de produto, largura e amplitude do produto, aplicação domínio. Os dados acima fornecidos estão apenas relacionados com o foco das empresas no mercado dos preenchimentos dérmicos.
Alguns dos principais players que operam no mercado são a Allergan (uma subsidiária da Abbvie, Inc.), Prollenium Medical Technologies, Suneva Medical, Revance Therapeutics, Inc., FillMed Laboratories, Anika Therapeutics, Inc, Ipsen Pharma, BIOXIS Pharmaceuticals, Zimmer Aesthetic Ltd ., Medytox, Contura International ltd., Shanghai Reyoungel Medical Technology Company Limited, Humedix (uma subsidiária da HUONS GLOBAL), Galderma Laboratories, LP, Merz North America, Inc. ),Croma-Pharma GmbH, Sinclair Pharma (uma subsidiária da Huadong Medicine Co., Ltd.),Teoxane, BioPlus Co., Ltd., Amalian, Givaudan, Mesoestetic, Sosum Global, DSM, IBSA Nordic ApS, entre outros.
SKU-
Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo
- Painel interativo de análise de dados
- Painel de análise da empresa para oportunidades de elevado potencial de crescimento
- Acesso de analista de pesquisa para personalização e customização. consultas
- Análise da concorrência com painel interativo
- Últimas notícias, atualizações e atualizações Análise de tendências
- Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Índice
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF EUROPE DERMAL FILLERS MARKET
1.4 LIMITATION
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCTS LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET END USER COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PORTER’S FIVE FORCES
4.2 PESTEL ANALYSIS
4.3 EPIDEMIOLOGY PROCEDURES PER COUNTRY
5 REGULATIONS OF EUROPE DERMAL FILLERS MARKET
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISING PREVALENCE OF MINIMALLY INVASIVE PROCEDURES
6.1.2 INCREASING GERIATRIC POPULATION
6.1.3 TECHNOLOGICAL ADVANCEMENTS IN DERMAL FILLERS
6.1.4 STRATEGIC INITIATIVES BY MARKET PLAYERS
6.2 RESTRAINTS
6.2.1 HIGH COST OF AESTHETIC PROCEDURES
6.2.2 ESCALATING PRODUCT RECALL
6.2.3 FDA GUIDELINES FOR ADVANCED DERMAL FILLER INJECTORS
6.3 OPPORTUNITIES
6.3.1 INCREASING HEALTHCARE EXPENDITURE
6.3.2 INCREASING FUNDING ACTIVITIES FOR AESTHETIC RESEARCH
6.3.3 ADVANCEMENT IN THE NEW DERMAL FILLERS
6.3.4 INCREASING COMPENSATION AND ACCIDENTAL CLAIMS FOR DERMAL FILLER
6.4 CHALLENGES
6.4.1 LACK OF SKILLED PROFESSIONALS
6.4.2 AVAILABILITY OF ALTERNATIVES
7 EUROPE DERMAL FILLERS MARKET, BY PRODUCT TYPE
7.1 OVERVIEW
7.2 BIODEGRADABLE DERMAL FILLERS
7.2.1 TEMPORARY BIODEGRADABLE
7.2.2 SEMI-PERMANENT BIODEGRADABLE
7.3 NON-BIODEGRADABLE DERMAL FILLERS
8 EUROPE DERMAL FILLERS MARKET, BY MATERIAL TYPE
8.1 OVERVIEW
8.2 NATURAL DERMAL FILLERS
8.2.1 HYALURONIC ACID
8.2.1.1 BY TYPE
8.2.1.1.1 MONOPHASIC FILLERS
8.2.1.2 BY TYPE
8.2.1.2.1 MONODENSIFIED
8.2.1.2.2 POLYDENSIFIED
8.2.1.2.3 BIPHASIC FILLERS
8.2.1.3 BY MATERIAL TYPE
8.2.1.3.1 SINGLE-PHASE
8.2.1.3.2 DUPLEX-PHASE
8.2.1.4 BY APPLICATION
8.2.1.4.1 FACE LIFT
8.2.1.4.2 RHINOPLASTY
8.2.1.4.3 RECONSTRUCTIVE SURGERY
8.2.1.4.4 FACIAL LINE CORRECTION
8.2.1.4.5 LIP ENHANCEMENT
8.2.1.4.6 SAGGING SKIN
8.2.1.4.7 CHEEK DEPRESSION
8.2.1.4.8 SKIN SMOOTHING
8.2.1.4.9 DENTISTRY
8.2.1.4.10 AESTHETIC RESTORATION
8.2.1.4.11 SCAR TREATMENT
8.2.1.4.12 CHIN AUGMENTATION
8.2.1.4.13 LIPOATROPHY TREATMENT
8.2.1.4.14 EARLOBE REJUVENATION
8.2.1.4.15 OTHERS
8.2.2 FAT
8.2.2.1 BY APPLICATION
8.2.2.1.1 FACE LIFT
8.2.2.1.2 RHINOPLASTY
8.2.2.1.3 RECONSTRUCTIVE SURGERY
8.2.2.1.4 FACIAL LINE CORRECTION
8.2.2.1.5 LIP ENHANCEMENT
8.2.2.1.6 SAGGING SKIN
8.2.2.1.7 CHEEK DEPRESSION
8.2.2.1.8 SKIN SMOOTHING
8.2.2.1.9 DENTISTRY
8.2.2.1.10 AESTHETIC RESTORATION
8.2.2.1.11 SCAR TREATMENT
8.2.2.1.12 CHIN AUGMENTATION
8.2.2.1.13 LIPOATROPHY TREATMENT
8.2.2.1.14 EARLOBE REJUVENATION
8.2.2.1.15 OTHERS
8.2.3 COLLAGEN
8.2.3.1 BY APPLICATION
8.2.3.1.1 FACE LIFT
8.2.3.1.2 RHINOPLASTY
8.2.3.1.3 RECONSTRUCTIVE SURGERY
8.2.3.1.4 FACIAL LINE CORRECTION
8.2.3.1.5 LIP ENHANCEMENT
8.2.3.1.6 SAGGING SKIN
8.2.3.1.7 CHEEK DEPRESSION
8.2.3.1.8 SKIN SMOOTHING
8.2.3.1.9 DENTISTRY
8.2.3.1.10 AESTHETIC RESTORATION
8.2.3.1.11 SCAR TREATMENT
8.2.3.1.12 CHIN AUGMENTATION
8.2.3.1.13 LIPOATROPHY TREATMENT
8.2.3.1.14 EARLOBE REJUVENATION
8.2.3.1.15 OTHERS
8.2.4 OTHERS
8.3 SYNTHETIC DERMAL FILLERS
8.3.1 POLY-L-LACTIC ACID
8.3.1.1 BY APPLICATION
8.3.1.1.1 FACE LIFT
8.3.1.1.2 RHINOPLASTY
8.3.1.1.3 RECONSTRUCTIVE SURGERY
8.3.1.1.4 FACIAL LINE CORRECTION
8.3.1.1.5 LIP ENHANCEMENT
8.3.1.1.6 SAGGING SKIN
8.3.1.1.7 CHEEK DEPRESSION
8.3.1.1.8 SKIN SMOOTHING
8.3.1.1.9 DENTISTRY
8.3.1.1.10 AESTHETIC RESTORATION
8.3.1.1.11 SCAR TREATMENT
8.3.1.1.12 CHIN AUGMENTATION
8.3.1.1.13 LIPOATROPHY TREATMENT
8.3.1.1.14 EARLOBE REJUVENATION
8.3.1.1.15 OTHERS
8.3.2 CALCIUM HYDROXYLAPATITE
8.3.2.1 BY APPLICATION
8.3.2.1.1 FACE LIFT
8.3.2.1.2 RHINOPLASTY
8.3.2.1.3 RECONSTRUCTIVE SURGERY
8.3.2.1.4 FACIAL LINE CORRECTION
8.3.2.1.5 LIP ENHANCEMENT
8.3.2.1.6 SAGGING SKIN
8.3.2.1.7 CHEEK DEPRESSION
8.3.2.1.8 SKIN SMOOTHING
8.3.2.1.9 DENTISTRY
8.3.2.1.10 AESTHETIC RESTORATION
8.3.2.1.11 SCAR TREATMENT
8.3.2.1.12 CHIN AUGMENTATION
8.3.2.1.13 LIPOATROPHY TREATMENT
8.3.2.1.14 EARLOBE REJUVENATION
8.3.2.1.15 OTHERS
8.3.3 POLYMETHYL-METHACRYLATE MICROSPHERES (PMMA)
8.3.3.1 BY APPLICATION
8.3.3.1.1 FACE LIFT
8.3.3.1.2 RHINOPLASTY
8.3.3.1.3 RECONSTRUCTIVE SURGERY
8.3.3.1.4 FACIAL LINE CORRECTION
8.3.3.1.5 LIP ENHANCEMENT
8.3.3.1.6 SAGGING SKIN
8.3.3.1.7 CHEEK DEPRESSION
8.3.3.1.8 SKIN SMOOTHING
8.3.3.1.9 DENTISTRY
8.3.3.1.10 AESTHETIC RESTORATION
8.3.3.1.11 SCAR TREATMENT
8.3.3.1.12 CHIN AUGMENTATION
8.3.3.1.13 LIPOATROPHY TREATMENT
8.3.3.1.14 EARLOBE REJUVENATION
8.3.3.1.15 OTHERS
8.3.4 POLYALKYLIMIDE
8.3.4.1 BY APPLICATION
8.3.4.1.1 FACE LIFT
8.3.4.1.2 RHINOPLASTY
8.3.4.1.3 RECONSTRUCTIVE SURGERY
8.3.4.1.4 FACIAL LINE CORRECTION
8.3.4.1.5 LIP ENHANCEMENT
8.3.4.1.6 SAGGING SKIN
8.3.4.1.7 CHEEK DEPRESSION
8.3.4.1.8 SKIN SMOOTHING
8.3.4.1.9 DENTISTRY
8.3.4.1.10 AESTHETIC RESTORATION
8.3.4.1.11 SCAR TREATMENT
8.3.4.1.12 CHIN AUGMENTATION
8.3.4.1.13 LIPOATROPHY TREATMENT
8.3.4.1.14 EARLOBE REJUVENATION
8.3.4.1.15 OTHERS
8.3.5 OTHERS
9 EUROPE DERMAL FILLERS MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 FACE LIFT
9.2.1 DEEP PLANE/SMAS FACE
9.2.2 MINI FACE LIFT
9.2.3 MID-FACE LIFT
9.2.4 JAW LINE
9.2.5 CUTANEOUS LIFT
9.2.6 TEMPORAL OR BROW LIFT
9.2.7 LIQUID FACE LIFT
9.2.8 OTHERS
9.2.8.1 JUVEDERM
9.2.8.2 RESTYLANE
9.2.8.3 SCULPTRA
9.2.8.4 DYSPORT
9.2.8.5 OTHERS
9.3 RHINOPLASTY
9.3.1 JUVEDERM
9.3.1.1 JUVEDERM XC
9.3.1.2 JUVEDERM ULTRA XC
9.3.1.3 JUVEDERM VOLUMA
9.3.1.4 JUVEDERM VOLBELLA
9.3.1.5 JUVEDERM VOLLURE XC
9.3.2 RESTYLANE
9.3.2.1 RESTYLANE SILK
9.3.2.2 RESTYLANE LYFT
9.3.2.3 RESTYLANE REFYNE
9.3.2.4 RESTYLANE DEFYNE
9.3.2.5 RESTYLANE-L
9.3.3 OTHERS
9.4 RECONSTRUCTIVE SURGERY
9.4.1 JUVEDERM
9.4.2 RESTYLANE
9.4.3 OTHERS
9.5 FACIAL LINE CORRECTION
9.5.1 DYNAMIC WRINKLES
9.5.2 STATIC WRINKLES
9.5.3 WRINKLE FOLDS
9.5.3.1 FOREHEAD LINES
9.5.3.2 WORRY LINES
9.5.3.3 BUNNIES
9.5.3.4 CROW’S FEET
9.5.3.5 LAUGH LINES
9.5.3.6 LIP LINES
9.5.3.7 MARIONETTE LINES
9.5.3.8 OTHERS
9.5.3.8.1 JUVEDERM
9.5.3.8.2 RESTYLANE
9.5.3.8.3 RADIESSE
9.5.3.8.4 BELOTERO
9.5.3.8.5 OTHERS
9.6 LIP ENHANCEMENT
9.6.1 JUVEDERM
9.6.1.1 JUVÉDERM XC
9.6.1.2 JUVÉDERM ULTRA XC
9.6.1.3 JUVÉDERM VOLUMA
9.6.1.4 JUVÉDERM VOLBELLA
9.6.1.5 JUVÉDERM VOLLURE XC
9.6.2 RESTYLANE
9.6.2.1 RESTYLANE SILK
9.6.2.2 RESTYLANE LYFT
9.6.2.3 RESTYLANE REFYNE
9.6.2.4 RESTYLANE DEFYNE
9.6.2.5 RESTYLANE-L
9.6.3 BELOTERO BALANCE
9.6.4 REVANESSE VERSA
9.6.5 HYLAFORM
9.6.6 PREVELLE SILK
9.6.7 OTHERS
9.7 SAGGING SKIN
9.7.1 JUVEDERM
9.7.2 RESTYLANE
9.7.3 BELOTERO
9.7.4 OTHERS
9.8 CHEEK DEPRESSION
9.8.1 JUVEDERM VOLUMA
9.8.2 RESTYLANE-LYFT
9.8.3 SCULPTRA
9.8.4 RADIESSE
9.8.5 OTHERS
9.9 SKIN SMOOTHENING
9.9.1 RESTYLANE
9.9.2 BELOTERO
9.9.3 BELLAFIL
9.9.4 OTHERS
9.1 DENTISTRY
9.10.1 JUVEDERM
9.10.2 RESTYLANE
9.10.3 RADIESSE
9.10.4 OTHERS
9.11 AESTHETIC RESTORATION
9.11.1 JUVEDERM
9.11.1.1 JUVEDERM ULTRA XC
9.11.1.2 JUVEDERM VOLLURE XC
9.11.1.3 JUVEDERM VOLBELLA XC
9.11.2 RESTYLANE
9.11.2.1 RESTYLANE-L
9.11.2.2 RESTYLANE SILK
9.11.2.3 RESTYLANE REFYNE AND DEFYNE
9.11.2.4 RESTYLANE LYFT
9.12 REVANESSE VERSA
9.13 SCULPTRA
9.14 RHA
9.14.1 RHA 2
9.14.2 RHA 3
9.14.3 RHA 4
9.15 BELLAFIL
9.16 BELOTERO BALANCE
9.17 OTHERS
9.18 LIP PLUM
9.18.1 RESTYLANE
9.18.2 BELOTERO
9.18.3 OTHERS
9.19 SCAR TREATMENT
9.19.1 JUVEDERM
9.19.2 RESTYLANE
9.19.3 RADIESSE
9.19.4 BELOTERO
9.19.5 PERLANE
9.19.6 OTHERS
9.19.6.1 KELOID SCARS
9.19.6.2 CONTRACTURE SCARS
9.19.6.3 HYPERTROPHIC SCARS
9.19.6.4 ACNE SCARS
9.19.6.5 OTHERS
9.2 CHIN AUGMENTATION
9.20.1 JUVEDERM VOLUMA XC
9.20.2 RESTYLANE
9.20.3 OTHERS
9.21 LIPOATROPHY TREATMENT
9.21.1 SCULPTRA
9.21.2 OTHERS
9.22 EARLOBE REJUVENATION
9.22.1 JUVEDERM
9.22.2 RESTYLANE
9.22.3 SCULPTRA
9.22.4 BELOTERO
9.22.5 ELLANSE
9.22.6 OTHERS
9.23 OTHERS
10 EUROPE DERMAL FILLERS MARKET, BY DRUG TYPE
10.1 OVERVIEW
10.2 BRANDED
10.2.1 JUVEDERM
10.2.1.1 JUVÉDERM XC
10.2.1.2 JUVÉDERM ULTRA XC
10.2.1.3 JUVÉDERM ULTRA PLUS XC
10.2.1.4 JUVÉDERM VOLBELLA
10.2.1.5 JUVÉDERM VOLUMA
10.2.1.6 JUVÉDERM VOLLURE
10.2.2 RESTYLANE
10.2.2.1 RESTYLANE-L
10.2.2.2 RESTYLANE REFYNE
10.2.2.3 RESTYLANE DEFYNE
10.2.2.4 RESTYLANE LYFT
10.2.2.5 RESTYLANE SILK
10.2.2.6 RESTYLANE KYSSE
10.2.2.7 RESTYLANE CONTOUR
10.2.3 RADIESSE
10.2.4 SCULPTRA
10.2.5 ELLANSE
10.2.5.1 ELLANSE-S
10.2.5.2 ELLANSE-M
10.2.5.3 ELLANSE-L
10.2.5.4 ELLANSE-E
10.2.6 BELLAFILL
10.2.7 AQUAMID
10.2.8 OTHERS
10.3 GENERIC
11 EUROPE DERMAL FILLERS MARKET, BY END USER
11.1 OVERVIEW
11.2 DERMATOLOGY CLINICS
11.3 HOSPITALS
11.4 AMBULATORY SURGICAL CENTERS
11.5 ACADEMIC RESEARCH INSTITUTES
11.6 OTHERS
12 EUROPE DERMAL FILLERS MARKET, BY DISTRIBUTION CHANNEL
12.1 OVERVIEW
12.2 DIRECT TENDER
12.3 DRUG STORES
12.4 RETAIL PHARMACY
12.5 ONLINE PHARMACY
12.6 OTHERS
13 EUROPE DERMAL FILLERS MARKET, BY GEOGRAPHY
13.1 EUROPE
13.1.1 GERMANY
13.1.2 ITALY
13.1.3 FRANCE
13.1.4 U.K.
13.1.5 SPAIN
13.1.6 RUSSIA
13.1.7 NETHERLANDS
13.1.8 SWITZERLAND
13.1.9 BELGIUM
13.1.10 TURKEY
13.1.11 REST OF EUROPE
14 EUROPE DERMA FILLERS MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: EUROPE
15 SWOT ANALYSIS
16 COMPANY PROFILE
16.1 ALLERGAN (A SUBSIDIARY OF ABBVIE INC.)
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 PRODUCT PORTFOLIO
16.1.5 RECENT DEVELOPMENTS
16.2 GALDERMA LABORATORIES, L.P
16.2.1 COMPANY SNAPSHOT
16.2.2 COMPANY SHARE ANALYSIS
16.2.3 PRODUCT PORTFOLIO
16.2.4 RECENT DEVELOPMENTS
16.3 MERZ NORTH AMERICA, INC (A SUBSIDIARY OF MERZ PHARMA)
16.3.1 COMPANY SNAPSHOT
16.3.2 COMPANY SHARE ANALYSIS
16.3.3 PRODUCT PORTFOLIO
16.3.4 RECENT DEVELOPMENTS
16.4 SINCLAIR PHARMA (A SUBSIDIARY OF HUADONG MEDICINE)
16.4.1 COMPANY SNAPSHOT
16.4.2 COMPANY SHARE ANALYSIS
16.4.3 PRODUCT PORTFOLIO
16.4.4 RECENT DEVELOPMENT
16.5 REVANCE THERAPEUTICS, INC.
16.5.1 COMPANY SNAPSHOT
16.5.2 REVENUE ANALYSIS
16.5.3 COMPANY SHARE ANALYSIS
16.5.4 PRODUCT PORTFOLIO
16.5.5 RECENT DEVELOPMENTS
16.6 AMALIAN
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT PORTFOLIO
16.6.3 RECENT DEVELOPMENTS
16.7 ANIKA THERAPEUTICS, INC.
16.7.1 COMPANY SNAPSHOT
16.7.2 REVENUE ANALYSIS
16.7.3 PRODUCT PORTFOLIO
16.7.4 RECENT DEVELOPMENTS
16.8 BIOPLUS CO., LTD.
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCT PORTFOLIO
16.8.3 RECENT DEVELOPMENTS
16.9 BIOXIS PHARMACEUTICALS
16.9.1 COMPANY SNAPSHOT
16.9.2 PRODUCT PORTFOLIO
16.9.3 RECENT DEVELOPMENTS
16.1 CONTURA INTERNATIONAL LTD.
16.10.1 COMPANY SNAPSHOT
16.10.2 PRODUCT PORTFOLIO
16.10.3 RECENT DEVELOPMENTS
16.11 CROMA-PHARMA GMBH
16.11.1 COMPANY SNAPSHOT
16.11.2 PRODUCT PORTFOLIO
16.11.3 RECENT DEVELOPMENT
16.12 DSM
16.12.1 COMPANY SNAPSHOT
16.12.2 PRODUCT PORTFOLIO
16.12.3 RECENT DEVELOPMENT
16.13 FILLMED
16.13.1 COMPANY SNAPSHOT
16.13.2 PRODUCT PORTFOLIO
16.13.3 RECENT DEVELOPMENT
16.14 GIVAUDAN
16.14.1 COMPANY SNAPSHOT
16.14.2 RECENT FINANCIALS
16.14.3 PRODUCT PORTFOLIO
16.14.4 RECENT DEVELOPMENT
16.15 HUMEDIX (A SUBSIDIARY OF HUONS EUROPE)
16.15.1 COMPANY SNAPSHOT
16.15.2 REVENUE ANALYSIS
16.15.3 PRODUCT PORTFOLIO
16.15.4 RECENT DEVELOPMENTS
16.16 IBSA FARMACEUTICI ITALIA SRL (A SUBSIDIARY OF IBSA INSTITUT BIOCHIMIQUE SA)
16.16.1 COMPANY SNAPSHOT
16.16.2 PRODUCT PORTFOLIO
16.16.3 RECENT DEVELOPMENT
16.17 IPSEN PHARMA.
16.17.1 COMPANY SNAPSHOT
16.17.2 REVENUE ANALYSIS
16.17.3 PRODUCT PORTFOLIO
16.17.4 RECENT DEVELOPMENT
16.18 MEDYTROX
16.18.1 COMPANY SNAPSHOT
16.18.2 PRODUCT PORTFOLIO
16.18.3 RECENT DEVELOPMENTS
16.19 MESOESTETIC
16.19.1 COMPANY SNAPSHOT
16.19.2 PRODUCT PORTFOLIO
16.19.3 RECENT DEVELOPMENTS
16.2 PROLLENIUM MEDICAL TECHNOLOGIES
16.20.1 COMPANY SNAPSHOT
16.20.2 PRODUCT PORTFOLIO
16.20.3 RECENT DEVELOPMENT
16.21 SHANGHAI REYOUNGEL MEDICAL TECHNOLOGY COMPANY LIMITED
16.21.1 COMPANY SNAPSHOT
16.21.2 PRODUCT PORTFOLIO
16.21.3 RECENT DEVELOPMENTS
16.22 SOSUM EUROPE
16.22.1 COMPANY SNAPSHOT
16.22.2 PRODUCT PORTFOLIO
16.22.3 RECENT DEVELOPMENT
16.23 SUNEVA MEDICAL
16.23.1 COMPANY SNAPSHOT
16.23.2 PRODUCT PORTFOLIO
16.23.3 RECENT DEVELOPMENT
16.24 TEOXANE SA
16.24.1 COMPANY SNAPSHOT
16.24.2 PRODUCT PORTFOLIO
16.24.3 RECENT DEVELOPMENTS
16.25 ZHEJIANG JINGJIA MEDICAL TECHNOLOGY CO., LTD
16.25.1 COMPANY SNAPSHOT
16.25.2 PRODUCT PORTFOLIO
16.25.3 RECENT DEVELOPMENT
16.26 ZIMMER AESTHETICS
16.26.1 COMPANY SNAPSHOT
16.26.2 PRODUCT PORTFOLIO
16.26.3 RECENT DEVELOPMENTS
17 QUESTIONNAIRE
18 RELATED REPORTS
Lista de Tabela
TABLE 1 COST OF DERMAL FILLERS
TABLE 2 COST OF PROCEDURE
TABLE 3 ASAPS PROCEDURE FACTS
TABLE 4 COMPENSATION COST FOR DERMAL FILLERS
TABLE 5 EUROPE DERMAL FILLERS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 6 EUROPE DERMAL FILLERS MARKET, BY PRODUCT TYPE, VOLUME, 2020-2029 (UNITS)
TABLE 7 EUROPE BIODEGRADABLE DERMAL FILLERS IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 8 EUROPE BIODEGRADABLE DERMAL FILLERS IN DERMAL FILLERS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 9 EUROPE BIODEGRADABLE DERMAL FILLERS IN DERMAL FILLERS MARKET, BY PRODUCT TYPE, VOLUME, 2020-2029 (UNITS)
TABLE 10 EUROPE NON-BIODEGRADABLE DERMAL FILLERS IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 11 EUROPE DERMAL FILLERS MARKET, BY MATERIAL TYPE, 2020-2029 (USD MILLION)
TABLE 12 EUROPE NATURAL DERMAL FILLERS IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 13 EUROPE NATURAL DERMAL FILLERS IN DERMAL FILLERS MARKET, BY MATERIAL TYPE, 2020-2029 (USD MILLION)
TABLE 14 EUROPE HYALURONIC ACID IN DERMAL FILLERS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 15 EUROPE MONOPHASIC FILLERS IN DERMAL FILLERS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 16 EUROPE HYALURONIC ACID IN DERMAL FILLERS MARKET, BY MATERIAL TYPE, 2020-2029 (USD MILLION)
TABLE 17 EUROPE HYALURONIC ACID IN DERMAL FILLERS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 18 EUROPE FAT IN DERMAL FILLERS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 19 EUROPE COLLAGEN IN DERMAL FILLERS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 20 EUROPE SYNTHETIC DERMAL FILLERS IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 21 EUROPE SYNTHETIC DERMAL FILLERS IN DERMAL FILLERS MARKET, BY MATERIAL TYPE, 2020-2029 (USD MILLION)
TABLE 22 EUROPE POLY-L-LACTIC ACID IN DERMAL FILLERS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 23 EUROPE CALCIUM HYDROXYLAPATITE IN DERMAL FILLERS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 24 EUROPE POLYMETHYL-METHACRYLATE MICROSPHERES (PMMA) IN DERMAL FILLERS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 25 EUROPE POLYALKYLIMIDE IN DERMAL FILLERS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 26 EUROPE DERMAL FILLERS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 27 EUROPE FACE LIFT IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 28 EUROPE FACE LIFT IN DERMAL FILLERS MARKET, BY TYPE, 2020- 2029 (USD MILLION)
TABLE 29 EUROPE FACE LIFT IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 30 EUROPE RHINOPLASTY IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 31 EUROPE RHINOPLASTY IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 32 EUROPE JUVEDERM IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 33 EUROPE RESTYLANE IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 34 EUROPE RECONSTRUCTIVE SURGERY IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 35 EUROPE RECONSTRUCTIVE SURGERY IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 36 EUROPE FACIAL LINE CORRECTION IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 37 EUROPE FACIAL LINE CORRECTION IN DERMAL FILLERS MARKET, BY TYPE, 2020- 2029 (USD MILLION)
TABLE 38 EUROPE FACIAL LINE CORRECTION IN DERMAL FILLERS MARKET, BY TYPE, 2020- 2029 (USD MILLION)
TABLE 39 EUROPE FACIAL LINE CORRECTION IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 40 EUROPE LIP ENHANCEMENT IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 41 EUROPE LIP ENHANCEMENT IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 42 EUROPE JUVEDERM IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 43 EUROPE RESTYLANE IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 44 EUROPE SAGGING SKIN IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 45 EUROPE SAGGING SKIN IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 46 EUROPE CHEEK DEPRESSION IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 47 EUROPE CHEEK DEPRESSION IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 48 EUROPE SKIN SMOOTHENING IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 49 EUROPE SKIN SMOOTHENING IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 50 EUROPE DENTISTRY IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 51 EUROPE DENTISTRY IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 52 EUROPE AESTHETIC RESTORATION IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 53 EUROPE AESTHETIC RESTORATION IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 54 EUROPE JUVEDERM IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 55 EUROPE RESTYLANE IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 56 EUROPE RHA IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 57 EUROPE LIP PLUM IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 58 EUROPE LIP PLUM IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 59 EUROPE SCAR TREATMENT IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 60 EUROPE SCAR TREATMENT IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 61 EUROPE SCAR TREATMENT IN DERMAL FILLERS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 62 EUROPE CHIN AUGMENTATION IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 63 EUROPE CHIN AUGMENTATION IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 64 EUROPE LIPOATROPHY TREATMENT IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 65 EUROPE LIPOATROPHY TREATMENT IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 66 EUROPE EARLOBE REJUVENTION IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 67 EUROPE EARLOBE REJUVENTION IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 68 EUROPE OTHERS IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 69 EUROPE DERMAL FILLERS MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)
TABLE 70 EUROPE BRANDED IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 71 EUROPE BRANDED IN DERMAL FILLERS MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)
TABLE 72 EUROPE JUVEDERM IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 73 EUROPE RESTYLANE IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 74 EUROPE ELLANSE IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 75 EUROPE GENERIC IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 76 EUROPE DERMAL FILLERS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 77 EUROPE DERMATOLOGY CLINICS IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 78 EUROPE HOSPITALS IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 79 EUROPE AMBULATORY SURGICAL CENTERS IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 80 EUROPE ACADEMIC RESEARCH INSTITUTES IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 81 EUROPE OTHERS IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 82 EUROPE DERMAL FILLERS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 83 EUROPE DIRECT TENDER IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 84 EUROPE DRUG STORES IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 85 EUROPE RETAIL PHARMACY IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 86 EUROPE ONLINE PHARMACY IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 87 EUROPE OTHERS IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
Lista de Figura
FIGURE 1 EUROPE DERMAL FILLERS MARKET: SEGMENTATION
FIGURE 2 EUROPE DERMAL FILLERS MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE DERMAL FILLERS MARKET: DROC ANALYSIS
FIGURE 4 EUROPE DERMAL FILLERS MARKET : EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE DERMAL FILLERS MARKET : COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE DERMAL FILLERS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE DERMAL FILLERS MARKET: DBMR MARKET POSITION GRID
FIGURE 8 EUROPE DERMAL FILLERS MARKET: MARKET END USER COVERAGE GRID
FIGURE 9 EUROPE DERMAL FILLERS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE DERMAL FILLERS MARKET: SEGMENTATION
FIGURE 11 RISING DEMAND FOR ANTI-AGING DRUGS, AND GROWING POPULARITY OF NON-SURGICAL OR MINIMALLY INVASIVE AESTHETICS PROCEDURES ARE EXPECTED TO DRIVE THE EUROPE DERMAL FILLERS MARKET IN THE FORECAST PERIOD 2022 TO 2029
FIGURE 12 BIODEGRADABLE DERMAL FILLER SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE DERMAL FILLERS MARKET IN 2022 & 2029
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF EUROPE DERMAL FILLERS MARKET
FIGURE 14 EUROPE DERMAL FILLERS MARKET: BY PRODUCT TYPE, 2021
FIGURE 15 EUROPE DERMAL FILLERS MARKET: BY PRODUCT TYPE, 2022-2029 (USD MILLION)
FIGURE 16 EUROPE DERMAL FILLERS MARKET: BY PRODUCT TYPE, CAGR (2022-2029)
FIGURE 17 EUROPE DERMAL FILLERS MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 18 EUROPE DERMAL FILLERS MARKET: BY MATERIAL TYPE, 2021
FIGURE 19 EUROPE DERMAL FILLERS MARKET, BY MATERIAL TYPE, 2022-2029 (USD MILLION)
FIGURE 20 EUROPE DERMAL FILLERS MARKET: BY MATERIAL TYPE, CAGR (2022-2029)
FIGURE 21 EUROPE DERMAL FILLERS MARKET: BY MATERIAL TYPE, LIFELINE CURVE
FIGURE 22 EUROPE DERMAL FILLERS MARKET : BY APPLICATION, 2021
FIGURE 23 EUROPE DERMAL FILLERS MARKET : BY APPLICATION, 2022-2029 (USD MILLION)
FIGURE 24 EUROPE DERMAL FILLERS MARKET : BY APPLICATION, CAGR (2022-2029)
FIGURE 25 EUROPE DERMAL FILLERS MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 26 EUROPE DERMAL FILLERS MARKET: BY DRUG TYPE, 2021
FIGURE 27 EUROPE DERMAL FILLERS MARKET, BY DRUG TYPE, 2022-2029 (USD MILLION)
FIGURE 28 EUROPE DERMAL FILLERS MARKET: BY DRUG TYPE, CAGR (2022-2029)
FIGURE 29 EUROPE DERMAL FILLERS MARKET: BY DRUG TYPE, LIFELINE CURVE
FIGURE 30 EUROPE DERMAL FILLERS MARKET: BY END USER, 2021
FIGURE 31 EUROPE DERMAL FILLERS MARKET: BY END USER, 2022-2029 (USD MILLION)
FIGURE 32 EUROPE DERMAL FILLERS MARKET: BY END USER, CAGR (2022-2029)
FIGURE 33 EUROPE DERMAL FILLERS MARKET: BY END USER, LIFELINE CURVE
FIGURE 34 EUROPE DERMAL FILLERS MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 35 EUROPE DERMAL FILLERS MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
FIGURE 36 EUROPE DERMAL FILLERS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 37 EUROPE DERMAL FILLERS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 38 EUROPE DERMAL FILLERS MARKET: SNAPSHOT (2021)
FIGURE 39 EUROPE DERMAL FILLERS MARKET: BY COUNTRY (2021)
FIGURE 40 EUROPE DERMAL FILLERS MARKET: BY COUNTRY (2022 & 2029)
FIGURE 41 EUROPE DERMAL FILLERS MARKET: BY COUNTRY (2021 & 2029)
FIGURE 42 EUROPE DERMAL FILLERS MARKET: BY PRODUCT TYPE (2022-2029)
FIGURE 43 EUROPE DERMA FILLERS MARKET: COMPANY SHARE 2021 (%)
Metodologia de Investigação
A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.
A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.
Personalização disponível
A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.